Join us in this next installment of our series, Patient-Doctor Perspectives, where we explore a diagnosis from the view of a patient and doctor. To celebrate the 100th episode of The Bloodline with LLS, we will be speaking with Mel Mann, a chronic myeloid leukemia (CML) survivor and Dr. Brian Druker, a physician researcher at Oregon Health Sciences University (OHSU). 

Mel shares how Dr. Druker’s research saved his life with the drug, Gleevec®, and we get to hear his inspirational message of how one person can make a difference. Dr. Druker discusses this revolutionary therapy, how it transformed the lives of CML patients like Mel, and how targeted treatments are continuing to transform how we treat cancer. 

Mentioned on this episode:

• Chronic Myeloid Leukemia
• The rise of precision medicine for patients with CML
• TKI Therapy
• Be The Match – Bone Marrow Donor Registry
• LLS Translational Research
• LLS Specialized Centers of Research Program
• Beat AML Master Clinical Trial
• Oral Parity Laws
• LLS Advocacy
• Clinical Trial Support Center
• LLS Myeloma Link

Additional LLS Support Resources:

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations 

Support for this episode provided by Pfizer.

The post Patient-Doctor Perspectives: Groundbreaking Research in CML first appeared on The Bloodline with Blood Cancer United Podcast.